Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,302.00
(
0.70%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.54
(
-0.11%
)
Bitcoin
74,193.22
(
0.34%
)
News Focus
News Focus

Replies to post #9476 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #9476 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

08/02/12 8:22 AM

#9478 RE: pollyvonwog #9476

That BAX and MNTA are now working on the third FoB in the collaboration presumably means that BAX has exercised the option to develop compounds #3-#6, which results in a $28M milestone payment to MNTA—see #msg-70258421.
icon url

DewDiligence

08/02/12 10:40 AM

#9483 RE: pollyvonwog #9476

Prediction: The first 3 FoB’s in the BAX-MNTA collaboration are Humira, Orencia, and Erbitux. (Craig Wheeler’s hint on today’s CC is consistent with this prediction.)